Literature DB >> 2995510

Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients.

Y Asano, N Itakura, Y Hiroishi, S Hirose, T Ozaki, K Kuno, T Nagai, T Yazaki, K Yamanishi, M Takahashi.   

Abstract

Replication of varicella-zoster virus (VZV) and immunologic responses to VZV were examined by a sensitive culture technique for viral isolation and standard immunologic assays in children after close exposure to wild-type VZV or after inoculation with strain Oka varicella vaccine. Naturally infected children who developed clinical varicella had viremia between five days before and one day after clinical onset of disease, with the highest isolation rate one and two days before onset, and seroconversion followed two days later. Virus was not isolated from blood 12 and 13 days after contact in subclinically infected children. In the vaccine recipients a positive skin test reaction to VZV was observed as early as four to five days after immunization, and antibody appeared later. Virus was not isolated from blood and throat of the vaccinees from three to 14 days after immunization.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995510     DOI: 10.1093/infdis/152.5.863

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview.

Authors:  M Takahashi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.

Authors:  Christiane S Eberhardt; Andreas Wieland; Tahseen H Nasti; Alba Grifoni; Elizabeth Wilson; D Scott Schmid; Bali Pulendran; Alessandro Sette; Edmund K Waller; Nadine Rouphael; Rafi Ahmed
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

4.  Platelet antigens in varicella associated thrombocytopenia.

Authors:  J Winiarski
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

Review 5.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

6.  Modulation of major histocompatibility class II protein expression by varicella-zoster virus.

Authors:  A Abendroth; B Slobedman; E Lee; E Mellins; M Wallace; A M Arvin
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Concerns on Vaccine against Varicella Caused by Varicella-Zoster Virus Infection.

Authors:  Wen-Bo Zeng; Fukun Zhang; Shuang Cheng; Jin-Yan Sun; Hongjie Shen; Min-Hua Luo
Journal:  Virol Sin       Date:  2020-05-28       Impact factor: 4.327

8.  Prophylaxis or modification of varicella by oral acyclovir after household exposure.

Authors:  Y Asano; S Suga; T Yoshikawa; T Ozaki
Journal:  Arch Dis Child       Date:  1994-05       Impact factor: 3.791

9.  Varicella zoster virus DNA in throat swabs.

Authors:  T Ozaki; H Miwata; Y Matsui; S Kido; K Yamanishi
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

10.  Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella.

Authors:  S Suga; T Yoshikawa; T Ozaki; Y Asano
Journal:  Arch Dis Child       Date:  1993-12       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.